Psychiatric Disorders after Switching to Dolutegravir: A Case Report of a 59-Year-Old Virosuppressed HIV-1 Positive Woman

We report a case of a woman who experienced psychiatric disorders after switching her antiretroviral therapy (c-ART) to dolutegravir (DTG). She is a 59-year-old HIV-1 positive woman with a recent story of cardiovascular disorders treated with beta-blockers, clopidogrel, and rosuvastatin. She underwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mengato, Daniele, Binazzi, Raffaella, Unterholzner, Ivan, Erne, Elke M., Tavella, Alicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180432/
https://www.ncbi.nlm.nih.gov/pubmed/32351747
http://dx.doi.org/10.1155/2020/9708913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180432/
https://www.ncbi.nlm.nih.gov/pubmed/32351747
http://dx.doi.org/10.1155/2020/9708913

Ejemplares similares